|
|
|
|
||
Re: Knocking on the 52 week door (once again)Back above $27 support on great additional data presented for T-rex. Not to be overconfident, but looks very good for approval and marketing the drug ahead of schedule. Analysts will start tripping over themselves to catch up with estimates and price targes, with soaring K sales (Q-3 CC Nov 6th) and every more so when T-rex busts out of its cage (maybe I've watched too many Jurassic Park movies - anything after the first one is too many). |
return to message board, top of board |